TW200637546A - Combination therapy - Google Patents

Combination therapy

Info

Publication number
TW200637546A
TW200637546A TW094144909A TW94144909A TW200637546A TW 200637546 A TW200637546 A TW 200637546A TW 094144909 A TW094144909 A TW 094144909A TW 94144909 A TW94144909 A TW 94144909A TW 200637546 A TW200637546 A TW 200637546A
Authority
TW
Taiwan
Prior art keywords
hydrochlorothiazide
combination therapy
telmisartan
angiotensin
treatment
Prior art date
Application number
TW094144909A
Other languages
English (en)
Chinese (zh)
Inventor
Helmut E Schumacher
Axel Riedel
Peter Boehm
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35589356&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200637546(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TW200637546A publication Critical patent/TW200637546A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)
TW094144909A 2004-12-17 2005-12-16 Combination therapy TW200637546A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63706204P 2004-12-17 2004-12-17

Publications (1)

Publication Number Publication Date
TW200637546A true TW200637546A (en) 2006-11-01

Family

ID=35589356

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094144909A TW200637546A (en) 2004-12-17 2005-12-16 Combination therapy

Country Status (15)

Country Link
EP (1) EP1827424A1 (enrdf_load_stackoverflow)
JP (1) JP2008524136A (enrdf_load_stackoverflow)
KR (1) KR20070097511A (enrdf_load_stackoverflow)
CN (1) CN101080225A (enrdf_load_stackoverflow)
AR (1) AR052052A1 (enrdf_load_stackoverflow)
AU (1) AU2005315855A1 (enrdf_load_stackoverflow)
BR (1) BRPI0519656A2 (enrdf_load_stackoverflow)
CA (1) CA2589493A1 (enrdf_load_stackoverflow)
EA (1) EA200701159A1 (enrdf_load_stackoverflow)
IL (1) IL183944A0 (enrdf_load_stackoverflow)
NO (1) NO20072325L (enrdf_load_stackoverflow)
PE (1) PE20060768A1 (enrdf_load_stackoverflow)
TW (1) TW200637546A (enrdf_load_stackoverflow)
UY (1) UY29274A1 (enrdf_load_stackoverflow)
WO (1) WO2006063737A1 (enrdf_load_stackoverflow)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232828B2 (en) 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
US8637078B2 (en) 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
EP1970053A1 (en) * 2007-03-14 2008-09-17 Boehringer Ingelheim Pharma GmbH & Co. KG Pharmaceutical composition
JP4879351B2 (ja) * 2007-10-19 2012-02-22 大塚製薬株式会社 医薬固形製剤
WO2009058950A2 (en) 2007-10-30 2009-05-07 Dr. Reddy's Laboratories Ltd. Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide
US20110008428A1 (en) 2008-03-19 2011-01-13 Ratiopharm Gmbh Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic
EP2310385B1 (en) 2008-07-31 2017-06-07 Takeda Pharmaceutical Company Limited Solid pharmaceutical composition
GB0822170D0 (en) * 2008-12-04 2009-01-14 Arrow Int Ltd Telmisartan with diuretic formulations
EP2443094B1 (en) 2009-06-19 2013-03-20 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of telmisartan
WO2011002425A2 (en) * 2009-07-02 2011-01-06 Bilgig Mahmut Pharmaceutical composition increasing solubility and stability
WO2011002423A2 (en) * 2009-07-02 2011-01-06 Mahmut Bilgic Solubility enhancing pharmaceutical composition
TR200906506A2 (tr) 2009-08-24 2011-03-21 Bi̇lgi̇ç Mahmut Telmisartan içeren katı dozaj formları.
WO2011161123A2 (en) 2010-06-21 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Multilayer pharmaceutical tablet comprising telmisartan and a diuretic
WO2014119767A1 (ja) * 2013-01-31 2014-08-07 沢井製薬株式会社 テルミサルタンとヒドロクロロチアジドとを含有する多層錠剤
ES2847904T3 (es) * 2013-07-23 2021-08-04 Daiichi Sankyo Co Ltd Medicamento para la prevención o el tratamiento de la hipertensión
CN106562973A (zh) * 2016-11-06 2017-04-19 成都先先先生物科技有限公司 一种抗高血压药物复方制剂
CN107501192A (zh) * 2017-08-15 2017-12-22 中国科学院上海药物研究所 替米沙坦与氢氯噻嗪的共晶
CN108653227A (zh) * 2018-08-09 2018-10-16 湖北舒邦药业有限公司 一种替米沙坦氢氯噻嗪片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229085C2 (de) * 1992-09-01 1996-07-11 Boehringer Mannheim Gmbh Längliche, teilbare Tablette
AU2002242676B2 (en) * 2002-01-16 2008-05-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof

Also Published As

Publication number Publication date
IL183944A0 (en) 2007-10-31
AR052052A1 (es) 2007-02-28
NO20072325L (no) 2007-07-06
KR20070097511A (ko) 2007-10-04
BRPI0519656A2 (pt) 2009-03-03
EA200701159A1 (ru) 2007-12-28
AU2005315855A1 (en) 2006-06-22
JP2008524136A (ja) 2008-07-10
PE20060768A1 (es) 2006-09-29
WO2006063737A1 (en) 2006-06-22
UY29274A1 (es) 2006-07-31
CA2589493A1 (en) 2006-06-22
EP1827424A1 (en) 2007-09-05
CN101080225A (zh) 2007-11-28

Similar Documents

Publication Publication Date Title
TW200637546A (en) Combination therapy
IL273765A (en) Combinations and forms of administration of therapeutic agents and combined treatment
UA101309C2 (ru) Антагонисты активина-actrii и их применение для повышения уровня эритроцитов
AU2003210300A1 (en) The use of tnf-alpha antagonist as drugs for the treatment of patients with sepsis and without suffering from total organ failure
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
EP2248519A3 (en) Non-mucoadhesive film dosage forms
WO2004010975A3 (en) Controlled drug delivery
NO20072931L (no) Forbedret doseringsregime av temozolomid for behandling av kreft basert pa pasientens MGMT-niva
TW200631578A (en) Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
BRPI0413974A (pt) combinação, método de tratamento de cáncer em um animal de sangue quente, composição farmacêutica, e, uso de uma combinação
MY137620A (en) Therapeutic treatment
EP1643999B8 (en) Pyridoxamine for use in the treatment of diabetic nephropathy in type ii diabetes
TW200501953A (en) Combination therapy for hypertension using lercanidipine and an angiotensin II receptor blocker
TW200509909A (en) Use of organic compounds
WO2009061445A3 (en) Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction
WO2008064138A3 (en) Personalized therapeutic treatment process
EA200901145A1 (ru) Применение рибофлавина в лечении гипертензии
WO2009134056A3 (ko) 약제학적 제제
WO2006030030A3 (de) System zur sequentiellen, transdermalen verabreichung von systemisch wirksamen substanzen
TH83710A (th) การบำบัดรวม
WO2004087132A8 (en) Combination drug therapy for treating hypertension
UA69994A (en) Method for correcting nephropathy in hypertension patients
WO2005011589A3 (en) Drug delivery methods and devices
RU2004134447A (ru) Применение препарата "мексикор" (2-этил-6-метил-3-оксипиридина сукцината) для лечения нефритов и нефропатий